EDITORIAL
Published on 06 Sep 2022
Editorial: Novel agents and combinations for treatment of malignant pleural mesothelioma in pre-clinical models
doi 10.3389/fphar.2022.1015959
- 761 views
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Novel Agents and Combinations for Treatment of Malignant Pleural Mesothelioma in Pre-clinical Models
Novel Agents and Combinations for Treatment of Malignant Pleural Mesothelioma in Pre-clinical Models
3,663
Total downloads
11k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 31 Mar 2022
How Our Continuing Studies of the Pre-clinical Inbred Mouse Models of Mesothelioma Have Influenced the Development of New Therapies
doi 10.3389/fphar.2022.858557
- 1,344 views
- 4 citations
REVIEW
Published on 07 Jan 2022
Novel Therapeutic Targets and Immune Dysfunction in Malignant Pleural Mesothelioma
doi 10.3389/fphar.2021.806570
- 2,511 views
- 7 citations
REVIEW
Published on 15 Dec 2021
A Glimpse in the Future of Malignant Mesothelioma Treatment
doi 10.3389/fphar.2021.809337
- 2,011 views
- 3 citations
ORIGINAL RESEARCH
Published on 21 Sep 2021
Quinacrine Has Preferential Anticancer Effects on Mesothelioma Cells With Inactivating NF2 Mutations
doi 10.3389/fphar.2021.750352
- 2,356 views
- 4 citations
Published in
Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Respiratory Pharmacology
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 11kTopic views
- 7,308Article views
- 3,663Article downloads